Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Al-Sarraf

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Oncology (Williston Park, N.Y.)|September 16, 2000
Chemotherapy in advanced nasopharyngeal cancerH Ali, M al-Sarraf
Cancer Investigation|January 1, 1995
Head and neck cancer: present status and future prospects of adjuvant chemotherapyM al-Sarraf, M Hussein
Cancer Treatment Reports|April 1, 1980
Phase II ftorafur therapy in previously treated squamous cell cancers of the head and neckM Campbell, M Al-Sarraf
International Journal of Radiation Oncology, Biology, Physics|October 15, 1995
Nasopharynx carcinoma: choice of treatmentM al-Sarraf, P W McLaughlin
Oncology|January 1, 1978
Monoclonal gammapathy, multiple myeloma and cancerR K Mohindra, M Al-Sarraf
American Journal of Clinical Oncology|October 1, 1984
Aclacinomycin. Phase II evaluation in advanced squamous carcinoma of the head and neckJ A Kish, M Al-Sarraf
Seminars in Oncology|June 1, 1993
Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neckF de Braud, M al-Sarraf
Lancet (London, England)|August 7, 1971
Effect of homologous plasma on lymphocyte transformation in cancer patients and controlsM al-Sarraf, V K Vaitkevicius
Cancer Treatment Reviews|December 1, 1979
Transfer factorM Al-Sarraf, L H Baker
Cancer Clinical Trials|January 1, 1981
Phase II study of hexamethylmelamine for disseminated prostatic carcinomaA Drelichman, R Brownlee, M Al-Sarraf
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Oncology (Williston Park, N.Y.)|September 16, 2000
Chemotherapy in advanced nasopharyngeal cancerH Ali, M al-Sarraf
Cancer Investigation|January 1, 1995
Head and neck cancer: present status and future prospects of adjuvant chemotherapyM al-Sarraf, M Hussein
Cancer Treatment Reports|April 1, 1980
Phase II ftorafur therapy in previously treated squamous cell cancers of the head and neckM Campbell, M Al-Sarraf
International Journal of Radiation Oncology, Biology, Physics|October 15, 1995
Nasopharynx carcinoma: choice of treatmentM al-Sarraf, P W McLaughlin
Oncology|January 1, 1978
Monoclonal gammapathy, multiple myeloma and cancerR K Mohindra, M Al-Sarraf
American Journal of Clinical Oncology|October 1, 1984
Aclacinomycin. Phase II evaluation in advanced squamous carcinoma of the head and neckJ A Kish, M Al-Sarraf
Seminars in Oncology|June 1, 1993
Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neckF de Braud, M al-Sarraf
Lancet (London, England)|August 7, 1971
Effect of homologous plasma on lymphocyte transformation in cancer patients and controlsM al-Sarraf, V K Vaitkevicius
Cancer Treatment Reviews|December 1, 1979
Transfer factorM Al-Sarraf, L H Baker
Cancer Clinical Trials|January 1, 1981
Phase II study of hexamethylmelamine for disseminated prostatic carcinomaA Drelichman, R Brownlee, M Al-Sarraf
Pageof 15